Randomized, Double-Blind, Placebo Controlled Phase II Trial of the Safety, Tolerability and Immunogenicity of Lyophilized ChimeriVax-WN02 West Nile Vaccine.
Phase of Trial: Phase II
Latest Information Update: 09 Apr 2014
At a glance
- Drugs West Nile virus vaccine (Primary)
- Indications West Nile virus infections
- Focus Adverse reactions; Pharmacodynamics
- Sponsors sanofi pasteur
- 01 Jan 2011 Results were published in the Journal of Infectious Diseases (part 2).
- 01 Jan 2011 Results were published in the Journal of Infectious Diseases (part 1).
- 14 Apr 2009 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History